

(In millions)
2016
2015
2014
Revenues:
Aflac Japan:
Net earned premiums
Cancer
$ 5,639
$ 4,933
$ 5,596
Medical and other health
3,429
3,092
3,770
Life insurance
4,469
4,021
4,495
Net investment income
2,554
2,436
2,662
Other income
40
31
32
Total Aflac Japan
16,131
14,513
16,555
Aflac U.S.:
Net earned premiums:
Accident/disability
2,469
2,391
2,303
Cancer
1,299
1,293
1,279
Other health
1,415
1,395
1,371
Life insurance
271
268
258
Net investment income
703
678
645
Other income
10
8
3
Total Aflac U.S.
6,167
6,033
5,859
Other business segments
275
225
43
Total business segment revenues
22,573
20,771
22,457
Realized investment gains (losses)
(1)
(208)
55
171
Corporate
284
282
281
Intercompany eliminations
(199)
(201)
(248)
Other non-operating income (loss)
109
(35)
(2)
67
Total revenues
$ 22,559
$ 20,872
$ 22,728
(1)
Excluding a gain of $85 in both 2016 and 2015 and $44 in 2014 related to the interest rate component of the change in fair value of
foreign currency swaps on notes payable which is classified as an operating gain when analyzing segment operations
(2)
Includes a loss of $20 related to the change in value of yen repatriation received in advance of settlement of certain foreign currency
derivatives. The loss was offset by derivative gains included in realized investment gains (losses).
99